Tanya Darrow
Medical · Henderson, NCNPI 1831368695
Payments from drug & device makers
Across 267 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Pfizer$762
- Lilly USA, LLC$439
- AbbVie$402
- Sanofi-aventis U.S. LLC$205
- GSK$178
- plus $1K from 34 others
What the payments were for
- Food & beverage$4,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,408 in reported general payments places this provider in the 85th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 80 | $61,581 |
| RybelsusSemaglutide | 37 | $52,575 |
| OzempicSemaglutide | 47 | $44,247 |
| FarxigaDapagliflozin Propanediol | 27 | $25,402 |
| LinzessLinaclotide | 17 | $24,298 |
| MounjaroTirzepatide | 18 | $20,498 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $19,368 |
| JardianceEmpagliflozin | 23 | $19,168 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $15,854 |
| TrulicityDulaglutide | 14 | $13,669 |
| JanuviaSitagliptin Phosphate | 21 | $11,710 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $10,383 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $10,331 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $10,270 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $7,538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $1,123 | $96,82184 claims |
| PfizerEliquis | $762 | $61,58180 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $108 | $46,16966 claims |
| Lilly USA, LLCMounjaro, Trulicity | $439 | $34,16732 claims |
| AbbVieLinzess | $402 | $24,29817 claims |
| GSKTrelegy Ellipta | $178 | $19,36822 claims |
| Boehringer IngelheimJardiance | $47 | $19,16823 claims |
| MerckJanuvia | $45 | $11,71021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 878 medical providers in North Carolina.
Other medical in Henderson
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.